Related Experiment Video

Updated: Aug 12, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

Left ventricular hypertrophy in hypertension--general and local trends in diagnosis and therapy

P Clarkson1, N Prasad, T M MacDonald

  • 1Department of Clinical Pharmacology, Ninewells Hospital and Medical School, Dundee.

Scottish Medical Journal
|April 1, 1994
PubMed

Insights

Left ventricular hypertrophy (LVH) is a serious predictor of cardiovascular events, not just a benign adaptation. Lifestyle changes and medications can help prevent and reverse LVH, improving patient outcomes.

Area of Science:

  • Cardiology
  • Echocardiography
  • Preventive Medicine

Background:

  • Left ventricular hypertrophy (LVH) is a common finding on echocardiograms.
  • LVH is an ominous predictor of future cardiovascular events.
  • ECG provides additional prognostic information and detects myocardial damage.

Purpose of the Study:

  • To highlight the prognostic significance of LVH.
  • To emphasize the role of echocardiography and ECG in LVH detection.
  • To discuss prevention and reversal strategies for LVH.

Main Methods:

  • Echocardiography for sensitive and specific LVH detection.
  • Electrocardiography (ECG) for prognostic information and myocardial damage assessment.
  • Review of studies on LVH prevention and reversal.

Main Results:

  • LVH is a significant risk factor for cardiovascular events.
  • Echocardiography is the primary diagnostic tool, complemented by ECG.
  • Decreasing LVH prevalence suggests successful prevention through hypertension and weight control.
  • Antihypertensive drugs, weight reduction, and salt restriction can reverse LVH.

Conclusions:

  • LVH is a critical cardiovascular risk factor requiring management.
  • Prevention strategies include controlling hypertension and weight.
  • Reversal of LVH through medical and lifestyle interventions improves outcomes.
  • Early detection and management of LVH are crucial for reducing morbidity and mortality.

More Related Videos

Biventricular Assessment of Cardiac Function and Pressure-Volume Loops by Closed-Chest Catheterization in Mice08:21

Biventricular Assessment of Cardiac Function and Pressure-Volume Loops by Closed-Chest Catheterization in Mice

Published on: June 15, 2020

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension10:03

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension

Published on: June 27, 2025

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...